Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 109Observational 1

Sponsor

Cancer Type

Sarcoma 1Classical hematology 1CNS 1

Conditions

Glioblastoma 12Astrocytoma 4Glioma 3Thrombocytopenia 1Oligodendroglioma 1Gliosarcoma 1Ependymoma 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Psychiatric Rehabilitation 4Immunohistochemistry 4Gene Expression Profiling 4Amplified Fragment Length Polymorphism Analysis 4Radiotherapy 3gadobenic acid 2Surveys and Questionnaires 2Polymerase Chain Reaction 2Microarray Analysis 2Mental Status and Dementia Tests 2Magnetic Resonance Imaging 2In Situ Hybridization, Fluorescence 2Gene Rearrangement 2Cytogenetic Analysis 2Comparative Genomic Hybridization 2gadoteridol 1Vincristine 1Tissue Banks 1Temozolomide 1Specimen Handling 1Respiratory Function Tests 1Radiosurgery 1Quality of Life 1Pulse Wave Analysis 1Positron-Emission Tomography 1Phlebotomy 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Methotrexate 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Central Nervous System Neoplasms × Temozolomide × Clear all
NCT00471653 2018-07-09

Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Terminated
10 enrolled
CNSClassical hematologySarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Thrombocytopenia, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡